Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Allergy Therapeutics (AGYTF) Weighted-Average Shares Outstanding (Diluted) data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Weighted-Average Shares Outstanding (Diluted) |
-- |
-- |
|
-- |
|
| Balance Sheet Financials | |
$44.88M |
|
$56.20M |
|
$67.34M |
|
$87.41M |
|
$35.19M |
|
$75.33M |
|
$88.70M |
|
$123.89M |
|
$-36.50M |
|
$-41.99M |
|
$-36.48M |
|
-- |
|
| Cash Flow Statement Financials | |
$-36.38M |
|
$-3.73M |
|
$40.33M |
|
$16.71M |
|
$16.55M |
|
$-0.16M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|